Pulmonary arterial hypertension in a patient with multiple myeloma during carfilzomib treatment: in search of better management.

Background:Multiple myeloma is a plasma cell dyscrasia accounting for 1% of neoplastic diseases and is the second most common hematologic malignancy after lymphoma. Pulmonary arterial hypertension ...